Minimally Invasive Surgery (MIS)
The gold standard
Patients appreciate the value of MIS because it can reduce postoperative pain, hospitalization, scarring and often lead to faster recovery. Meanwhile, clinicians benefit from easier, less time-consuming procedures that reduce damage to tissue. That’s why MIS has evolved into the gold standard for efficient, low-risk surgical procedures.
In MIS, clinicians make smaller incisions, so implanted devices need to have not only lower profiles but also lubricious coatings so they’re easy to insert and maneuver inside the body. Leading device manufacturers incorporate DSM biomaterials, which for many years have enjoyed proven clinical success in implants for MIS.
Advancing surgical procedures
In cardiovascular medicine, our biomaterials can be used or are being explored by medical device companies for them to utilize in the manufacturing of their devices which are employed in a variety of procedures, including replacing aortic valves and implanting ventricular assist devices, cardiac assist devices, and central venous catheters. In orthopedics, they’re essential for arthroscopic procedures, especially knee and shoulder surgery, and many ligament and soft tissue repairs.
Probing new frontiers
DSM provides biomaterials to medical device manufacturers so they can create products that enable clinicians to probe the vascular frontiers in procedures such as stent placement, balloon angioplasty and vein grafts; and for delivering drugs via catheter to treat illnesses or relieve pain. Our implantable biomaterials also benefit urology, where catheterized patients appreciate the minimized discomfort of catheters with lubricious, hydrophilic coatings. In women’s health, MIS is also becoming an excellent alternative to invasive surgery.
As clinicians look to safer, more efficient ways to perform surgery, they’ll find new applications for minimally invasive procedures, because the benefits to patients are paramount. That’s our mission at DSM. It’s why we go to work every day and why we keep developing new and innovative biomaterials.